Global Amniotic Membrane Market industry valued approximately USD 820 million in 2016 is anticipated to grow with a healthy growth rate of more than 10% over the forecast period 2017-2025. Amniotic Membrane are a sack that surrounds and protects the embryo, enclosing the amniotic cavity. It is used as a skin substitute and a surgical biomaterial in various applications such as clinical treatment of pathological conditions, which includes ocular disorders, skin wound healing, and reconstructive surgery. Rise in transplantation activities along with the awareness regarding the benefits of amniotic membrane in individuals are anticipated to propel the market over forecast period.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

Product:
§ Cryopreserved
§ Lyophilization

Application:
§ Surgical Wounds
§ Ophthalmology
§ Others

End-Use:
§ Hospital
§ Ambulatory Settings
§ Specialized Clinics
§ Research Centers & Laboratory

Regions:
§ North America
o U.S.
o Canada
§ Europe
o UK
o Germany
§ Asia Pacific
o China
o India
o Japan
§ Latin America
o Brazil
o Mexico
§ Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are; Skye Biologics Inc., IOP Ophthalmics, Amniox Medical, Inc., Amnio Technology, LLC, Applied Biologics LLC, Alliqua BioMedical, Inc., Human Regenerative Technologies, LLC, Derma Sciences Inc., MiMedx Group, Inc. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Amniotic Membrane Market Study:

§ Key Consulting Companies & Advisors
§ Large, medium-sized, and small enterprises
§ Venture capitalists
§ Value-Added Resellers (VARs)
§ Third-party knowledge providers
§ Investment bankers
§ Investors